rs137852417
Positions:
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PP3_StrongPP5_Moderate
The NM_000132.4(F8):c.1648C>T(p.Arg550Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000166 in 1,206,680 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Genomes: 𝑓 0.0000090 ( 0 hom., 1 hem., cov: 22)
Exomes 𝑓: 9.1e-7 ( 0 hom. 1 hem. )
Consequence
F8
NM_000132.4 missense
NM_000132.4 missense
Scores
10
4
3
Clinical Significance
Conservation
PhyloP100: 2.99
Genes affected
F8 (HGNC:3546): (coagulation factor VIII) This gene encodes coagulation factor VIII, which participates in the intrinsic pathway of blood coagulation; factor VIII is a cofactor for factor IXa which, in the presence of Ca+2 and phospholipids, converts factor X to the activated form Xa. This gene produces two alternatively spliced transcripts. Transcript variant 1 encodes a large glycoprotein, isoform a, which circulates in plasma and associates with von Willebrand factor in a noncovalent complex. This protein undergoes multiple cleavage events. Transcript variant 2 encodes a putative small protein, isoform b, which consists primarily of the phospholipid binding domain of factor VIIIc. This binding domain is essential for coagulant activity. Defects in this gene results in hemophilia A, a common recessive X-linked coagulation disorder. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.99
PP5
Variant X-154957061-G-A is Pathogenic according to our data. Variant chrX-154957061-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 10223.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chrX-154957061-G-A is described in Lovd as [Likely_pathogenic]. Variant chrX-154957061-G-A is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
F8 | ENST00000360256.9 | c.1648C>T | p.Arg550Cys | missense_variant | 11/26 | 1 | NM_000132.4 | ENSP00000353393.4 | ||
F8 | ENST00000647125.1 | n.*1524C>T | non_coding_transcript_exon_variant | 12/14 | ENSP00000496062.1 | |||||
F8 | ENST00000647125.1 | n.*1524C>T | 3_prime_UTR_variant | 12/14 | ENSP00000496062.1 |
Frequencies
GnomAD3 genomes AF: 0.00000899 AC: 1AN: 111199Hom.: 0 Cov.: 22 AF XY: 0.0000299 AC XY: 1AN XY: 33401
GnomAD3 genomes
AF:
AC:
1
AN:
111199
Hom.:
Cov.:
22
AF XY:
AC XY:
1
AN XY:
33401
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 9.13e-7 AC: 1AN: 1095481Hom.: 0 Cov.: 30 AF XY: 0.00000277 AC XY: 1AN XY: 360893
GnomAD4 exome
AF:
AC:
1
AN:
1095481
Hom.:
Cov.:
30
AF XY:
AC XY:
1
AN XY:
360893
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000899 AC: 1AN: 111199Hom.: 0 Cov.: 22 AF XY: 0.0000299 AC XY: 1AN XY: 33401
GnomAD4 genome
AF:
AC:
1
AN:
111199
Hom.:
Cov.:
22
AF XY:
AC XY:
1
AN XY:
33401
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Hereditary factor VIII deficiency disease Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jul 01, 1992 | - - |
Mild hemophilia A Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Versiti Diagnostic Laboratories, Versiti, Inc | Apr 10, 2024 | The missense variant F8 c.1648C>T, p.Arg550Cys (p.R550C; legacy p.R531C) in exon 11 changes amino acid arginine at codon 550 to cysteine. The arginine at this residue is fairly well conserved among species. This amino acid change occurs at the interface of the A1 and A2 domains. Pathogenic variants in F8 are associated with X-linked hemophilia A characterized by mild to severe bleeding due to a quantitative or qualitative deficiency in factor VIII. This sequence variant has been previously reported in patients with mild to moderate hemophilia A, both with and without the development of inhibitors (PMID:1924291; PMID:8547094; PMID:16769589; PMID:17286776; PMID:20331753; PMID:23926300; PMID:29296726). Patients carrying this variant show discrepancy between 1-stage and 2-stage factor VIII activity assays, with a lower measurement recorded with 2-stage assay (PMID:17286776). This variant was observed in 6 males and 3 females within our laboratory cohort. All 6 males within our laboratory cohort had clot based factor VIII activity levels consistent with moderate or mild hemophilia A; 3 out of 6 males had VWD 2N ruled out by either a 2N binding assay or by negative next generation sequencing. The minor allele frequency of this variant in the general population is 0.000008993 (GnomAD v3). No functional data is available for this variant. In silico computational evidence (REVEL) predicts the variant to be damaging (>=0.644 ); however, computational evidence alone is not sufficient to classify a variant. Different variants causing a change at the same amino acid (c.1648C>G, p.R550G; c.1649G>A, p.R550H; c.1649G>T, p.R550L; c.1649G>C, p.R550P) have also been reported in patients with mild to severe hemophilia A (PMID:1924291; PMID:19473423; PMID:8547094; PMID:11157485; PMID:18179574; PMID:29296726). Functional studies of the alternate p.R550H variant using recombinant protein demonstrated a similar discrepant activity between 1-stage and 2-stage assays and showed an increased rate of A2 subunit dissociation correlating with inactivation of FVIIIa (PMID:11157485). In summary, the collective evidence supports F8 c.1648C>T, p.Arg550Cys as a pathogenic variant for mild to moderate hemophilia A. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Benign
DANN
Uncertain
DEOGEN2
Pathogenic
D
FATHMM_MKL
Benign
D
LIST_S2
Benign
T
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
M
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D
REVEL
Pathogenic
Sift
Uncertain
D
Sift4G
Pathogenic
D
Polyphen
D
Vest4
MutPred
Loss of sheet (P = 0.0181);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at